PFA
ALAB icon

Pathway Financial Advisers’s Astera Labs ALAB Stock Holding History

Pathway Financial Advisers’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-130
Closed -$7.84K – 451
2024
Q2 		$7.84K Buy
+130
New +$9.02K ﹤0.01% 361

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Pathway Financial Advisers's ALAB Position: Q3 2024 in Review

Pathway Financial Advisers sold out of Astera Labs (ALAB) in Q3 2024, closing a stake of 130 shares — an estimated $7.84K sold.

Pathway Financial Advisers first reported a position in ALAB in Q2 2024 and held it in 1 quarter. The position peaked at $7.84K in Q2 2024. 245 funds tracked by Wall St. Rank hold ALAB as of Q3 2024.

  • Pathway Financial Advisers reported no remaining Astera Labs position as of Q3 2024 after selling out during the quarter.
  • Pathway Financial Advisers sold 130 Astera Labs shares in Q3 2024, an estimated $7.84K.
  • Pathway Financial Advisers first reported a position in Astera Labs in Q2 2024 and held it in 1 quarter.
  • Pathway Financial Advisers's Astera Labs position peaked at $7.84K in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Astera Labs as of Q3 2024.

Based on Pathway Financial Advisers's 13F filing for Q3 2024, filed 24 Oct 2024.